Every 10-Q that Global Medical REIT Inc. (GMRE) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow GMRE and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full GMRE filings page.
Chiron Real Estate Inc. reported first-quarter 2026 rental revenue of $38.1 million, up from $34.6 million a year earlier, driven by its 189-building healthcare portfolio. Net income was $1.7 million, down from $3.7 million, as higher operating, G&A and non-cash depreciation and amortization offset revenue growth.
After paying $2.5 million of preferred dividends, common stockholders recorded a net loss of $0.06 per share versus earnings of $0.16 a year ago. Operating cash flow remained solid at $13.4 million, while net real estate investments stayed near $1.5 billion and Credit Facility borrowings totaled $672.0 million.
Subsequent to quarter end, Chiron agreed to acquire three luxury seniors housing communities totaling $425 million in Alexandria and North Bethesda, to be run as operating properties. It also arranged an up to $100 million delayed-draw Series C convertible preferred investment and reduced its quarterly common dividend by about 36% to prioritize funding this growth strategy.
Global Medical REIT Inc. (GMRE) filed its Q3 2025 report, showing steady rent growth but a quarterly loss driven by an impairment. Rental revenue was $37,036 in the quarter and total revenue was $37,229. Expenses rose on depreciation and interest, and the Company recorded a $6,281 impairment, resulting in net loss attributable to common stockholders of $6,001, or $0.45 per share.
For the nine months, total revenue reached $109,816 with operating cash flow of $51,977. GMRE acquired a five‑property medical real estate portfolio and completed five dispositions across Kansas, Oregon, Florida, Tennessee, and Illinois. The Company executed a 1‑for‑5 reverse stock split effective September 19, 2025, and reported 13,407,358 common shares outstanding as of November 3, 2025.
Balance sheet highlights include total assets of $1,273,238 and Credit Facility borrowings of $711,700 gross (Revolver $211,700, Term Loans $500,000). Subsequent to quarter end, on October 8, 2025 GMRE amended and restated its Credit Facility, extending the Revolver to October 2029, splitting Term Loan A into tranches maturing in 2029, 2030, and 2031, and removing the 0.10% SOFR spread adjustment.
GMRE’s Q2 2025 10-Q shows modest top-line growth offset by higher financing costs. Rental revenue rose 10.7% YoY to $37.9 m, lifting total revenue to $38.0 m. Operating expense inflation (+13%) and an 15% jump in interest expense limited operating income to $0.4 m (vs. $1.4 m LY). Net income turned positive at $0.6 m, yet after $1.5 m preferred dividends common shareholders posted a $0.8 m loss (-$0.01/sh).
Balance sheet leverage increased. Net real-estate investment grew $42 m to $1.20 b after acquiring five facilities for $79.7 m and selling three for $9.1 m gains. Credit-facility borrowings expanded $67 m to $699 m, pushing total liabilities to $772 m (+10%). Equity fell 6% to $525 m, driven by dividend distributions and an $8.2 m OCI hit from falling swap values. Cash flow from operations covered common and preferred dividends ($34.4 m OCF vs. $33.4 m payouts). Management flags $24.6 m of committed cap-ex (≈$12.6 m in next 12 mo).
Key trends: 1) revenue growth from acquisitions continues; 2) elevated debt and rising SOFR expose earnings to rate risk despite hedges; 3) dividend remains higher than GAAP earnings but covered by FFO proxy cash flow; 4) active capital recycling—three small Q1-Q2 sales and a 12.5% JV stake launched in late-2024.